# GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
> **ANDA214407** · Abbreviated New Drug Application (Generic) · Sponsor: L PERRIGO CO · Approved 2022-02-01
## Drug
- **FDA Application Number:** ANDA214407
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE
- **Generic name:** GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE
- **Active ingredients:** GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** L PERRIGO CO
- **Manufacturer:** Cardinal Health 110, LLC. dba Leader
- **First approval:** 2022-02-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214407)
---
*AI Analytics · CC0 1.0*